My main reserach interest is drug development in the porphyrias, a group of rare inborn errors of metabolism. This includes the entire life circle of a drug, i.e., basic research, trial design, approval and access. I am working in diagnostics and research at the Municipal Hospital in Zurich, the Swiss Reference Centers for Porphyrias. Besides that, I am a lecturer at the University of Zurich and the University of Applied Sciences Zurich. Together with a group of dedicated patient-scientists, I co-founded the International Porphyria Patient Network (IPPN), a not-for-profit organisation of patients and carers that provides support and counselling for patients suffering from one of the eight forms of porphyria, and collaborates with national and international porphyria patient associations in scientific, medical, and healthcare policy matters.